| Friend or foe? Evidence indicates endogenous exosomes can deliver functional gRNA and Cas9 protein R Chen, H Huang, H Liu, J Xi, J Ning, W Zeng, C Shen, T Zhang, G Yu, ... Small 15 (38), 1902686, 2019 | 95 | 2019 |
| Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection Y Yan, L Allweiss, D Yang, J Kang, J Wang, X Qian, T Zhang, H Liu, ... Emerging microbes & infections 8 (1), 879-894, 2019 | 64 | 2019 |
| Hepatitis B virus virions produced under nucleos (t) ide analogue treatment are mainly not infectious because of irreversible DNA chain termination Y Liu, H Liu, Z Hu, Y Ding, XB Pan, J Zou, J Xi, G Yu, H Huang, MT Luo, ... Hepatology 71 (2), 463-476, 2020 | 39 | 2020 |
| Compensatory upregulation of aldo-keto reductase 1B10 to protect hepatocytes against oxidative stress during hepatocarcinogenesis Y Liu, J Zhang, H Liu, G Guan, T Zhang, L Wang, X Qi, H Zheng, CC Chen, ... American Journal of Cancer Research 9 (12), 2730, 2019 | 22 | 2019 |
| Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis H Liu, J Cheng, U Viswanathan, J Chang, F Lu, JT Guo PLoS pathogens 17 (11), e1010057, 2021 | 21 | 2021 |
| Over-gap PCR amplification to identify presence of replication-competent HBV DNA from integrated HBV DNA: an updated occult HBV infection definition Y Liu, W Zeng, J Xi, H Liu, H Liao, G Yu, X Chen, F Lu Journal of Hepatology 70 (3), 557-559, 2019 | 11 | 2019 |
| Junceellolide B, a novel inhibitor of Hepatitis B virus X Li, H Liu, W Cheng, J Wang, H Zhang, F Lu, X Chen, W Lin Bioorganic & Medicinal Chemistry 28 (16), 115603, 2020 | 10 | 2020 |
| Synthesis of 4-oxotetrahydropyrimidine-1 (2H)-carboxamides derivatives as capsid assembly modulators of hepatitis B virus N Hwang, H Ban, J Chen, J Ma, H Liu, P Lam, J Kulp, S Menne, J Chang, ... Medicinal Chemistry Research 30, 459-472, 2021 | 7 | 2021 |
| Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy Q Zhao, H Liu, L Tang, F Wang, G Tolufashe, J Chang, JT Guo Antiviral research, 105782, 2023 | 6 | 2023 |
| Sex-determining region Y box 4 (SOX4) suppresses Hepatitis B virus replication by inhibiting hepatocyte nuclear factor 4α expression S Shi, M Liu, J Xi, H Liu, G Guan, C Shen, Z Guo, T Zhang, Q Xu, ... Antiviral Research 176, 104745, 2020 | 6 | 2020 |
| The A1762T/G1764A mutations enhance HBV replication by alternating viral transcriptome D Yang, J Zou, G Guan, X Feng, T Zhang, G Li, H Liu, H Zheng, J Xi, G Yu, ... Journal of Medical Virology 95 (10), e29129, 2023 | 5 | 2023 |
| LncCDCA3L inhibits cell proliferation via a novel RNA structure‐based crosstalk with CDCA3 in hepatocellular carcinoma Y Wang, Y Liu, T Zhang, G Guan, T Mao, H Liu, J Zhang, F Lu, X Chen Liver International 42 (6), 1432-1446, 2022 | 5 | 2022 |
| Precore mutation enhances viral replication to facilitate persistent infection especially in HBeAg-negative patients G Li, D Yang, X Liu, T Zhang, H Liu, J Zou, Z Xu, X Chen, L Dai, H Chen, ... Virologica Sinica 39 (2), 319-330, 2024 | 2 | 2024 |
| Gene Editing: Friend or Foe? Evidence Indicates Endogenous Exosomes Can Deliver Functional gRNA and Cas9 Protein (Small 38/2019) R Chen, H Huang, H Liu, J Xi, J Ning, W Zeng, C Shen, T Zhang, G Yu, ... Small 15 (38), 1970205, 2019 | 1 | 2019 |
| Mechanism of action, clinical research and development, and application prospect of hepatitis B virus core protein allosteric modulators LIU Hui, LU Fengmin, GUO Jutao 临床肝胆病杂志 38 (8), 1726-1732, 2022 | | 2022 |
| LncCDCA3L inhibits cell proliferation via a novel RNA structure-based crosstalk with CDCA3 in hepatocellular carcinoma | | |
